50
Participants
Start Date
August 3, 2023
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2025
Liverscope® exam
Participants will undergo a LiverScope® examination to measure liver proton density fat fraction (PDFF, primary) and T1 and T2 values (exploratory).
MR exam
Participants will undergo an advanced MR examination to measure liver PDFF, T1, T2, and liver stiffness values.
FibroScan® exam (optional)
Participants may undergo a FibroScan® exam (optional) to evaluate liver fat and liver stiffness.
Blood draw
Participants will undergo a blood draw (approximately 10 mL) for measurement of CBC, platelets, and complete metabolic panel with transaminases.
Body measurements
Participants will have their height, weight, waist circumference, and hip circumference measured.
Questionnaires
Participants will be asked to fill out questionnaires to collect information about their alcohol consumption, history of cigarette smoking, presence of diabetes, and history of liver disease and medications
University of California San Diego, La Jolla
Livivos, Inc.
UNKNOWN
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
NIH
University of California, San Diego
OTHER